Edwards Lifesciences Corp (EW)

Common Stock
Sell: $79.80|Buy: $84.50|Change: 1.18 (1.47%)

Company profile

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Address

One Edwards Way
Irvine
CA
USA
92614


Telephone

+1 800 4243278


Sector 

Healthcare


Previous key dates

NameKey Date
Edwards Lifesciences Corp First Quarter Earnings Conference Call for 20262026-04-23T17:00:00
Edwards Lifesciences Corp First Quarter Earnings Results for 20262026-04-23T00:00:00
Leerink Global Healthcare Conference2026-03-11T10:00:00
Barclays 28th Annual Global Healthcare Conference2026-03-10T10:00:00
TD Cowen 46th Annual Health Care Conference 20262026-03-02T09:50:00
Edwards Lifesciences Corp Citi’s Unplugged Medtech and Life Sciences Access Day 20262026-02-26T10:15:00
Edwards Lifesciences Corp Annual Report for 20252026-02-25T00:00:00
Edwards Lifesciences Corp Fourth Quarter Earnings Conference Call for 20252026-02-10T17:00:00
Edwards Lifesciences Corp Fourth Quarter Earnings Results for 20252026-02-10T00:00:00
J.P. Morgan Healthcare Conference2026-01-12T11:15:00
Edwards Lifesciences Corp Third Quarter Earnings Conference Call for 20252025-10-30T17:00:00
Edwards Lifesciences Corp Third Quarter Earnings Result for 20252025-10-30T00:00:00
Edwards Lifesciences Corp - Investor and Analyst TAVR & TMTT Q&A Session at TCT Conference Call 20252025-10-27T17:00:00
Edwards Lifesciences Corp Second Quarter Earnings Conference Call for 20252025-07-24T17:00:00
Edwards Lifesciences Corp Second Quarter Earnings Results for 20252025-07-24T00:00:00
BofA Securities 2025 Health Care Conference2025-05-13T10:40:00
Edwards Lifesciences Corp Annual General Meeting for 20252025-05-08T10:00:00
Edwards Lifesciences Corp First Quarter Earnings Conference Call for 20252025-04-23T17:00:00
Edwards Lifesciences Corp First Quarter Earnings Result for 20252025-04-23T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.